RACHEL MUNCH: Open Payments
NPI 1912629932 · TAMPA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,804 in 96 payments from 15 companies in 2025. Trend: 2023 $573 · 2024 $1,618 · 2025 $1,804
Food & beverage: $1,732Education: $72
| Company | Payments | Amount |
|---|---|---|
| Arcutis Biotherapeutics, Inc. | 36 | $638 |
| ABBVIE INC. | 19 | $317 |
| GENZYME CORPORATION | 7 | $155 |
| Amgen Inc. | 6 | $104 |
| Janssen Biotech, Inc. | 2 | $89 |
| Novartis Pharmaceuticals Corporation | 4 | $84 |
| Regeneron Healthcare Solutions, Inc. | 2 | $74 |
| Incyte Corporation | 3 | $67 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $66 |
| Galderma Laboratories, L.P. | 3 | $53 |
Products named: Zoryve, DUPIXENT, RINVOQ, SKYRIZI, Otezla, TREMFYA, Opzelura, SPEVIGO.
Industry payments across FL — which companies pay providers there.
